Mark Richards, former President of Medipharm has launched a new business, MLR Innovations specializing in the manufacturing and development of animal health and nutritional products.
MLR Innovations focuses its energies on probiotics, silage inoculants, gel products, novel nutritional additives and other inventive technologies for the livestock, companion animal and crop preservation industries. The company manufactures primarily private label products.
MLR has licensed the patented Lactobacillus plantarum (Jl:l) bacterial culture and Fermented Oat Based Feeding Technology from ProEquo AB of Sweden. ProEquo specializes in the manufacturing and distribution of probiotics in the EU. This probiotic strain is equine specific and has been well documented showing improved equine health and enhanced equine performance.
In addition, MLR is closely collaborating with PROJ-X, Inc. MLR and PROJ-X have jointly developed an equine product called E-H2O 500/200. This technology allows vitamin E to be readily absorbed into the blood 3 times higher and faster than traditional forms of Vitamin E.